Methods We compared RNA expression of ACE2 and TMPRSS2 in blood (paired-end
sequencing), ileal, and colonic mucosal biopsies (microarray) from 138 patients with …

Background and Aims The presence of gastrointestinal symptoms and high levels of viral
RNA in the stool suggest active severe acute respiratory syndrome coronavirus 2 (SARS …

Background Patients with inflammatory bowel disease (IBD) have intestinal inflammation
and are treated with immune-modulating medications. In the face of the coronavirus disease …

Background Patients with inflammatory bowel disease [IBD] are considered
immunosuppressed, but do not seem more vulnerable for COVID-19. Nevertheless …

Background And Aims The host receptor for severe acute respiratory syndrome coronavirus
2, angiotensin-converting enzyme 2 (ACE2), is highly expressed in small bowel (SB). Our …

Gastrointestinal symptoms are common in COVID-19 patients, especially in younger
patients. Our hypothesis was that intestinal SARS-CoV-2 receptor ACE2 expression …

A series of pneumonia cases caused by 2019 novel coronavirus (2019-nCoV, also named
COVID-19) are being reported globally. Based on recent publications, 1–3 the most common …

Little is known of the patterns of expression of ACE2 and TMPRSS2 or the clinical
characteristics of COVID-19 in patients with COVID-19 and colorectal cancer. We found in …

Since December 2019, several cases of pneumonia of unknown etiology have been
reported in Wuhan, Hubei Province, China. On 7 January 2020, a novel coronavirus was …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has a direct
impact on the gastrointestinal system, as up to 50% of fecal samples from coronavirus …